Yinshan Tang

Yinshan Tang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
YTYinshan Tang
Yinshan Tang
AXAnping XU
Anping XU
SSShujun Shao
Shujun Shao
YZYou Zhou
You Zhou
BXBing Xiong
Bing Xiong
ZLZhigang Li
Zhigang Li
Electroacupuncture (EA) has become popular for its adjustable strength and frequency and easy quantification in the clinic and has demonstrated therapeutic potential for Alzheimer’s disease (AD). However, the mechanism remains unknown. Abnormally activated c-Jun N-terminal kinase (JNK) has been closely related to the pathological process of AD. The aim of this study was to investigate the effect of EA on cognitive impairment and the role of the JNK signaling pathway in AD model amyloid precursor protein (APP)/presenilin 1 (PS1) mice. The memory and learning ability of each group was assessed using the Morris Water Maze (MWM). Immunofluorescence, immunohistochemistry and Western blot were performed to measure the expression of APP, JNK, phosphorylated (P-)JNK, mitogen-activated protein kinase 4 (MKK4), MKK7, c-Jun and caspase-3 in hippocampal tissue samples in APP/PS1 mice after EA intervention. Obvious cognitive deficits were observed in the AD model APP/PS1 mice in the MWM test and were associated with JNK signaling pathway activation and APP upregulation. Four weeks of EA significantly ameliorated the cognitive impairments and inhibited JNK signaling pathway activation and APP upregulation. Taken together, the findings demonstrated that EA can reverse cognitive deficits and substantially lower the burden of APP in AD model APP/PS1 mice, at least partially through inhibiting the JNK signaling pathway and regulating apoptosis signals. Therefore, EA may offer an effective alternative therapeutic approach for AD.

20 November 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
AXAnping Xu
Anping Xu
QZQingtao Zeng
Qingtao Zeng
YTYinshan Tang
Yinshan Tang
XWXin Wang
Xin Wang
XYXiaochen Yuan
Xiaochen Yuan
ZLZhigang Li
Zhigang Li
Background: Alzheimer’s disease (AD) is mainly manifested as a continuous and progressive decline in cognitive ability. Neurofibrillary tangles (NFTs) are pathological hallmarks of AD and due to accumulated phosphorylated Tau. Glycogen synthase kinase-3β (GSK3β), as a major Tau kinase and a downstream target of the serine protein kinase B (AKT) signaling pathway, can regulate Tau phosphorylation in AD. Importantly, the AKT/GSK3β signaling pathway is involved in glucose metabolism, and abnormal glucose metabolism is found in the AD brain. Numerous studies have shown that electroacupuncture (EA), which is thought to be a potential complementary therapeutic approach for AD, can protect cognitive ability to a certain extent.Objective: The purpose of this experiment was to investigate whether the protective and beneficial mechanism of EA on cognition was mediated by the AKT/GSK3β signaling pathway, thereby improving glucose metabolism and Tau phosphorylation in the brain.Methods: EA was applied to the Baihui (GV20) and Yintang (GV29) acupoints of 6-month-old amyloid precursor protein (APP)/presenilin-1 (PS1) mice for 20 min, and then quickly prick Shuigou (GV26) acupoint. The intervention was performed once every other day for 28 days. The Morris water maze (MWM) test was performed on C57BL/6N (Non-Tg) mice, APP/PS1 (Tg) mice and EA-treated Tg (Tg + EA) mice to evaluate the effect of EA therapy on cognitive function. 18F-FDG positron emission tomography (PET), immunohistochemistry, and western blotting (WB) were used to investigate the possible mechanism underlying the effect of EA on AD.Results: EA treatment significantly improved the cognition of APP/PS1 mice and the glucose uptake rate in the hippocampus. Furthermore, EA inhibited the phosphorylation of Tau (Ser199 and Ser202) proteins by inducing AKT (Ser473) and GSK3β (Ser9) phosphorylation.Conclusion: These results demonstrate that EA intervention protects cognition by enhancing glucose metabolism and inhibiting abnormal phosphorylation of Tau protein in the AD model mice, and the AKT/GSK3β pathway might play an irreplaceable role in the regulation process.

15 May 2019 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
YTYinshan Tang
Yinshan Tang
SSShujun Shao
Shujun Shao
YGYu Guo
Yu Guo
YZYou Zhou
You Zhou
JCJin Cao
Jin Cao
DXDulian Xiang
Dulian Xiang
Increased amyloid-β (Aβ) plaque deposition is thought to be the main cause of Alzheimer’s disease (AD). β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the key protein involved in Aβ peptide generation. Excessive expression of BACE1 might cause overproduction of neurotoxins in the central nervous system. Previous studies indicated that BACE1 initially cleaves the amyloid precursor protein (APP) and may subsequently interfere with physiological functions of proteins such as PKA, which is recognized to be closely associated with long-term potentiation (LTP) level and can effectively ameliorate cognitive impairments. Therefore, revealing the underlying mechanism of BACE1 in the pathogenesis of AD might have a significant impact on the future development of therapeutic agents targeting dementia. This study examined the effects of electroacupuncture (EA) stimulation on BACE1, APP, and p-PKA protein levels in hippocampal tissue samples. Memory and learning abilities were assessed using the Morris water maze test after EA intervention. Immunofluorescence, immunohistochemistry, and western blot were employed to assess the distribution patterns and expression levels of BACE1, APP, and p-PKA, respectively. The results showed the downregulation of BACE1 and APP and the activation of PKA by EA. In summary, EA treatment might reduce BACE1 deposition in APP/PS1 transgenic mice and regulate PKA and its associated substrates, such as LTP to change memory and learning abilities.

11 December 2019 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Open access
PDF file
YJYing Jin
Ying Jin
LYLi Yu
Li Yu
FXFangfang Xu
Fangfang Xu
JZJie Zhou
Jie Zhou
BXBing Xiong
Bing Xiong
WJWeifeng Jin
Weifeng Jin
Background and Objective Dan-Hong injection, which comprises extracts of Salvia miltiorrhiza and Carthamus tinctorius, promotes blood circulation and reduces blood stasis. Combination of S. miltiorrhiza and C. tinctorius is more effective in treating cerebral ischemia than S. miltiorrhiza alone. This study aimed to examine the pharmacokinetic characteristics of four active ingredients of S. miltiorrhiza and C. tinctorius, namely danshensu (DSS), hydroxysafflor yellow A (HSYA), and salvianolic acid A (SAA) and B (SAB) in normal and cerebral ischemia rats. Methods Normal and cerebral ischemia rats were injected via the tail vein with each active ingredient, and blood was collected through the jaw vein at different time points. The plasma concentration of the compatibility group was analyzed by high-performance liquid chromatography, and pharmacokinetic parameters were determined using Pharmacokinetic Kinetica 4.4 software. Results The pharmacokinetics of the four active ingredients in the normal and cerebral ischemia rats were consistent with a two-compartment model. The area under the concentration–time curve was higher in normal rats than in cerebral ischemia rats, with a highly significant difference for SAA (P < 0.01). Clearance rates were lower in normal rats than in cerebral ischemia rats, with DSS showing the most significant difference (P < 0.01). Furthermore, there were significant differences between normal and cerebral ischemia rats in the distribution phase-elimination half life for DSS, SAA, and HSYA, as well as in the apparent volume of distribution for the central compartment for DSS and HSYA (P < 0.01). The plasma concentrations of the four active ingredients were higher in normal rats than in cerebral ischemia rats. Conclusion Cerebral ischemia rats showed higher drug clearance rates and longer retention times than normal rats, which may be due to destruction of the blood–brain barrier during cerebral ischemia–reperfusion. The four active ingredients likely integrated and interacted with each other to affect target sites in the brain to protect against cerebral ischemic injury.

1 September 2019 in Medicine
Verified
Journal Article
Open access
JZJin Zhou
Jin Zhou
CJChenglong Jiang
Chenglong Jiang
PWPeng Wang
Peng Wang
SHShen He
Shen He
ZQZirong Qi
Zirong Qi
YTYinshan Tang
Yinshan Tang
Background: Overactive bladder (OAB) is a common disease in the urinary system. The morbidity is increasing annually. Herbal medicines have been pervasively used in the therapy of OAB. However, systematic review or meta-analysis has not been found to assess the effects and safety of herbal medicines in curing OAB at present. Hence, the systematic review is conducted to scientifically and methodically evaluate the value of its effectiveness and safety of herbal medicines on OAB. Methods: We will collect all randomized controlled trials (RCTs) to assess the effectiveness and safety of herbal medicines on OAB. The RCTs will be searched from the electronic databases, including 7 English databases, consisting of PubMed, Excerpta Medica Database (EMBASE), MEDLINE, Web of Science, Cochrane Library, SpringerLink, and WHO International Clinical Trials Registry Platform (ICTRP), and 4 Chinese databases, namely Wanfang Chinese database, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), and Chinese Scientific Journal Database (VIP), others valid search strategy will be adopted. All the RCTs will be assessed from the databases establishment to July 2019. We will perform the meta-analysis of RCTs when the dissertation is appropriate. We will conduct an assessment including data synthesis, bias risk, and subgroup analysis by means of Review Manager software (RevMan) V.5.3.5 software while the setting condition is met. Results: This systematic view and meta-analysis will generate a summary based on the current relevant research to calculate the effects and safety of herbal medicines in promoting the therapy of OAB. Furthermore, it will provide a high-quality synthesis for participants who use herbal medicine to cure OAB. Conclusion: The summary of our systematic view will verify whether herbal medicines intervention could be an effective and safety approach in curing OAB.

11 November 2026 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
XHXiangrong Hou
Xiangrong Hou
HHHui Hong
Hui Hong
KLKaicheng Li
Kaicheng Li
QZQingze Zeng
Qingze Zeng
SWShuyue Wang
Shuyue Wang
CWChao Wang
Chao Wang
Background: Peak width of skeletonized mean diffusivity (PSMD) is an automated diffusion marker that captures white matter microstructural damage more sensitively than conventional small vessel disease markers. We investigated the cross sectional and longitudinal associations of PSMD and amyloid β (A β ) burden with cognition, and whether concomitant cerebral amyloid angiopathy (CAA) modifies these relationships in mild cognitive impairment (MCI). Methods: A total of 124 MCI patients were included from the Alzheimer’s Disease Neuroimaging Initiative, classified as CAA-MCI or non-CAA MCI by Boston criteria version 2.0. Cross-sectional and longitudinal associations between baseline PSMD, amyloid burden, and cognitive outcomes were assessed using linear regression, linear mixed-effects models, and Cox proportional hazards models. Results: PSMD showed strong cross-sectional associations with processing speed and executive function, however this association was not modified by CAA status. No significant difference for longitudinal cognition changes between CAA and non-CAA groups. Within CAA-MCI, higher PSMD correlated with lower A β burden but not with cognition. Over 4 years, PSMD did not predict decline after correction for multiple comparisons in both CAA and non-CAA groups. Greater A β burden predicted multi- domain decline and dementia conversion in both groups, and the A β -associated decline in global cognition was steeper in CAA-MCI. Conclusion: PSMD indexed current processing speed and executive function rather than subsequent change, independently of conventional small vessel disease markers and of CAA, whereas A β burden drove longitudinal decline and dementia conversion. The two biomarkers therefore appear to capture processes unfolding on different time scales. Whether concomitant CAA modifies amyloid-related decline requires confirmation in larger cohorts.